Because people that carry the APOE e4 gene variant show up to possess a bigger risk of serious problems, the FDA recommends getting tested to the gene variant before beginning treatment with lecanemab or donanemab. Find out more Discovery You are able to rely on the domain skills of our https://jakec186alu6.slypage.com/profile